The mass transfers of O 2 , glucose, NH 3 , urea and amino acids across the portal-drained viscera (PDV) and the liver were quantified, by arterio-venous techniques, during the last 4 h of a 100 h infusion of 0 (basal), 150 or 400 mol NH 4 HCO 3 /min into the mesenteric vein of three sheep given 800 g grass pellets/d and arranged in a 3 × 3 Latin-square design. Urea irreversible loss rate (ILR) was also determined by continuous infusion of [ 14 C]urea over the last 52 h of each experimental period. PDV and liver movements of glucose, O 2 and amino acids were unaltered by NH 4 HCO 3 administration, although there was an increase in PDV absorption of non-essential amino acids (P = 0⋅037) and a trend for higher liver O 2 consumption and portal appearance of total amino acid-N, glucogenic and non-essential amino acids at the highest level of infusion. PDV extraction of urea-N (P = 0⋅015) and liver removal of NH 3 (P Ͻ 0⋅001), release of urea-N (P = 0⋅002) and urea ILR (P = 0⋅001) were all increased by NH 4 HCO 3 infusion. Hepatic urea-N release (y) and NH 3 extraction (x) were linearly related (R 2 0⋅89), with the slope of the regression not different from unity, both for estimations based on liver mass transfers (1⋅16; SE 0⋅144; P b 1 = 0⋅31) and [
NH 3 of both endogenous and gastrointestinal origin is normally removed completely by the liver and converted to urea. Hepatic ureagenesis depends, however, on the coordinated supply of N to the ornithine cycle from two different precursors, mitochondrial NH 3 and cytosolic aspartate. Blood free amino acids are, together with NH 3 , the only N-substrates extracted by the liver in amounts sufficient to mantain the rates of ureagenesis observed in ruminants in vivo (Huntington, 1989; Reynolds et al. 1991; Lobley et al. 1995) . If amino acids were the predominant N-donors to aspartate via transamination reactions with glutamate, the immediate aspartate-N precursor, then the ratio NH 3 removal : urea-N production across the liver should be 0⋅5 or even lower because NH 3 derived from the 5-amido group of glutamine can also contribute N to the mitochondrial synthesis of carbamoyl phosphate (Nissim et al. 1992) . Such ratios, on both an absolute and incremental basis, have been observed in several studies with ruminants in vivo (see reviews by Reynolds, 1992; Parker et al. 1995; Lescoat et al. 1996) , leading to the hypothesis that, to detoxify NH 3 , the liver would require an equal N input from amino acids. This would penalize net protein availability to the animal. Other data, however, yield values greater than 0⋅5 (see Huntington, 1986; Seal & Reynolds, 1993; Parker et al. 1995) , suggesting that blood NH 3 can provide N to both urea-N precursors. Indeed, the equimolar conversion of NH 3 to urea-N has been firmly established by isotopic studies in vitro (Luo et al. 1995; Brosnan et al. 1996) . Although this efficient conversion has not always been observed in response to increased hepatic NH 3 extraction in vivo (Huntington, 1986; Reynolds et al. 1991; Goetsch et al. 1996) , this may relate to experimental conditions in which both diet quality and/or quantity were altered. Thus, factors other than portal NH 3 flow that might also stimulate ureagenesis from amino acids, were changed simultaneously.
Ureagenesis can influence both liver energy expenditure and gluconeogenesis. The theoretical energy costs of urea synthesis have been exceeded in many studies in vivo (e.g. Reynolds et al. 1991; Lobley et al. 1995) , but the data are confounded by the number of factors altered by the nutritional treatments imposed. Similarly, evidence for interaction between NH 3 -stimulated ureagenesis and hepatic glucose production comes primarily from studies in vitro (Weekes et al. 1978; Martinrequero et al. 1993) , where nonphysiological concentrations and balances of substrates are often employed.
The objective of the present experiment was to investigate the response of hepatic urea-N production and amino acid removal to increasing rates of NH 3 supply in growing wethers. This was examined by use of chronic (4 d) infusions of NH 4 HCO 3 into the mesenteric vein. Additionally, the consequences for energy metabolism, based on changes in liver O 2 demand and glucose output, were quantified.
Materials and methods

Animals
Three Suffolk cross-bred wethers (35-40 kg body weight), surgically prepared with indwelling catheters in the posterior aorta, portal, hepatic and mesenteric veins (Lobley et al. 1995) , were placed in metabolism cages under continuous lighting conditions and adjusted to receiving 71 g grass pellets (850 g/d; 920 g DM/kg; 10 MJ metabolizable energy/ kg DM; 22 g N/kg DM) every 2 h using automatic feeders. Water was offered ad libitum. A temporary jugular catheter was inserted 24 h before the start of each experimental period.
Design
The experiment was arranged as a 3 × 3 Latin square with three experimental periods each of 100 h separated by a 15 d interval. Throughout each experimental period the sheep were infused into the mesenteric vein catheter with one of: physiological saline (0⋅15 M-NaCl), 0⋅45 M-NH 4 HCO 3 or 1⋅2 M-NH 4 HCO 3 (both in 0⋅15 M-NaCl) at a rate of 20 g/h, to provide 0 (C0), 150 (C150) or 400 (C400) mol NH 4 HCO 3 /min plus a constant input of 50 mol NaCl/ min. At 48 h after the start of each experimental period, a solution containing 1 mM-[ 14 C]urea (9⋅25 kBq/g) in physiological saline was infused for 52 h into the right jugular vein catheter at a rate of 4 g/h. At 94 h after the start of the experimental period, a 0⋅1 M-sodium p-amino hippuric acid, 0⋅05 M-sodium phosphate buffer (pH 7⋅4) solution containing 400 IU heparin/g was infused into the mesenteric vein catheter at a rate of 20 g/h for 6 h. All the solutions were sterilized and the infusions performed by means of peristaltic pumps.
Samples
Four simultaneous blood samples were continuously withdrawn from the aorta, portal and hepatic veins at hourly intervals (10 ml/h per catheter) during the last 4 h (96-100 h) of each experimental period, using a peristaltic pump. The collection lines were allowed to pass through ice-cold water to reduce both risk of blood clotting and enzyme activities in the blood samples. The blood samples were collected directly into 10 ml syringes stored in ice-cold water. An additional mixed blood sample (10-15 ml) was collected during each experimental period for determination of blood and plasma DM. Three urine samples were also collected during the last 4 h of the experimental period. An additional urine sample was collected 18 h before the [ 14 C]urea infusion for determination of background radioactivity.
Blood analysis
Blood samples in each syringe were carefully mixed and analysed for blood p(O 2 ), p(CO 2 ), pH, bicarbonate and haemoglobin concentration immediately after collection using a Blood Gas Analyser (Acid Base Laboratory ABL3, Radiometer, Copenhagen, Denmark). The packed cell volume was determined by the microhaematocrit method.
One portion (0⋅5 g) of blood was deproteinized with 5 g 120 g/l TCA and processed for gravimetric determination of p-amino hippuric acid as previously described (Lobley et al. 1995) . Then 4 ml blood was centrifuged at 1200 g for 10 min at 4Њ and the plasma (approximately 2⋅5 ml) collected. Two portions (0⋅5 ml) of plasma were used for the enzymic determination of NH 3 (Mondzac et al. 1965 ) and glucose concentration (Bergmeyer, 1985) by automated procedures (Kone Autoanalyzer, Espoo, Finland). Two additional portions of 1⋅2 and 0⋅9 ml plasma were stored at −20Њ until analysis for urea and amino acid concentration respectively.
The four arterial, portal vein and hepatic vein plasma samples from each experimental period were pooled in proportion to the plasma flow (pooled sample weight, approximately 0⋅5 g), and processed for amino acid analysis of physiological fluids with an Alpha Plus Amino Acid Analyser (Pharmacia-LKB Biochrom Ltd, Cambridge, Cambs, UK) as described by Lobley et al. (1995) .
One portion of 0⋅3 g plasma was enriched with 0⋅3 g of a solution of 5 mM-[ 15 N 15 N]urea (99⋅7 atom %), carefully mixed, deproteinized with 0⋅1 ml sulfosalicyclic acid (480 g/l) and centrifuged at 7000 g for 5 min. From the supernatant fraction, the N-methyl-N-(tertiary butyldimethylsilyl) trifluoroacetamide derivative of urea was prepared as described by Calder & Smith (1980) . Plasma urea enrichment was determined by electron impact GC-mass spectrometry analysis on a VG Trio-1 mass spectrometer (VG Masslab, Manchester, UK) coupled to a Hewlett Packard 5890 GC (VG Organic, Manchester, UK; Calder & Smith, 1980) . The fragment ions at m/z 231 and 233 were monitored under selective ion recording conditions.
Urine analysis
The specific radioactivity of urea was determined on 4 g urine acidified with 1 g 250 g/l TCA. Scintillation liquid (10 ml) (Ultima Gold, Camberra Packard Ltd, Pangbourne, Berkshire, UK) was added to 0⋅2 g acidified urine and the 14 C radioactivity was measured by liquid scintillation counting (Tri-carb 1900 TR, Camberra Packard Ltd) using an external standard correction (Lobley et al. 1996b) . A portion (0⋅5 g) of the acidified urine was diluted for determination of urea concentration by a Technicon automated procedure (Marsh et al. 1965) .
Calculations
O 2 concentration in blood (mmol/l) was calculated as
where H is the haemoglobin content of blood (g/l), 1⋅34 is the maximum O 2 transport capacity of the haemoglobin (ml O 2 /g haemoglobin), 22⋅4 is the gas constant (ml O 2 /mmol O 2 ) and S is the O 2 saturation of the haemoglobin estimated from the equation developed by Margaria (1963) :
In this equation, the value of p(O 2 ) has been corrected (cp(O 2 )) to allow for the effects of p(CO 2 ) and blood pH on S according to the formula proposed by Kelman (1966) :
and k 1 (0⋅005491) and k 2 (1042) were estimated by fitting the equation to the data obtained for the O 2 saturation of sheep haemoglobin at different O 2 tensions reported by Bartels & Harms (1959) . Blood flows (F, g/min) were calculated as:
where F p and F h are the blood flows in the portal and hepatic veins respectively, I is the infusion rate of p-amino hippuric acid (mol/min) and C a , C p and C h are the concentrations of p-amino hippuric acid (mol/g) in posterior aorta, portal vein and hepatic vein respectively. Plasma flows and whole-blood water flows (g/min) were calculated as:
respectively, where F is the relevant blood flow and PCV and BDM are the corresponding packed cell volume and blood DM content of the sample respectively.
Mass transfers of metabolites and O 2 across the portaldrained viscera (PDV) and the liver (mol/min or mmol/ min) were calculated as:
where F p and F h are the blood (for O 2 and NH 3 ), plasma (for amino acids and glucose) or whole-blood water (for urea) flows in the portal vein and hepatic vein (g/min) respectively, and C a , C p and C h are the concentrations of O 2 in blood (mol/g) and metabolites in plasma (amino acids, NH 3 and glucose; nmol/g) or plasma water fraction (urea, estimated as plasma urea concentration : plasma water fraction; mol/g) in posterior aorta, portal vein and hepatic vein respectively. Urea transfers were calculated as whole-blood water transfers under the assumption that plasma and blood water fractions have equal urea concentrations (Milano, 1997) . NH 3 concentrations in blood and plasma were assumed to be equal (Milano, 1997) and thus plasma concentration and blood flows quantified to yield transfers across the PDV and the liver. Virtually no glucose is transported within the erythrocytes in sheep (Arai et al. 1995) and only for glycine and threonine is plasma transfer across the PDV significantly smaller than blood movements (Lobley et al. 1996a) . Therefore, glucose and amino acid movements across the PDV and the liver were estimated as plasma transfers.
The irreversible loss rate (ILR, mol/min) of urea was calculated as:
I r /Sr, where I r is the infusion rate (kBq/min) of [ 
Statistical analysis
The data were initially analysed by ANOVA for the effects of treatment (rate of infusion of NH 4 HCO 3 ), block (animals) and period, with two residual degrees of freedom. In the case of portal vein NH 3 concentration and urea and NH 3 transfers across the PDV and the liver, the mean squares for the effect of period and block were equal to, or lower than, that of the residual and never significant. For these data, the period and block sum of squares were therefore included in the residual sum of squares and the data re-analysed for the effect of treatment alone, with 6 d.f. for the residual mean square (RMS). The relationships between hepatic NH 3 removal, hepatic urea-N release and urea-N IRL were studied by regression analysis.
Results
Animals and catheter patency
All animals completed the experiment and the catheters maintained their full patency (i.e. they allowed blood collection as well as infusion of solutions) during the experiment, with the exception of one mesenteric catheter which, after the first experimental period, was suitable only for infusion.
Blood variables (Table 1)
The 4 d infusion of NH 4 HCO 3 had no measurable effect on blood pH, p(CO 2 ), HCO 3 − or haemoglobin concentration and therefore the acid-base status of the sheep remained unaltered during the experiment.
Plasma ammonia, urea and amino acid concentrations (Table 1)
An apparent small reduction of 14 mol/l was detected during treatment C150 in the average arterial concentration of NH 3 (P Ͻ 0⋅05) which otherwise lay between 60 and 75 mol/l, within the ranges normally reported for sheep (e.g. Orzechowski et al. 1988; Lobley et al. 1995 Lobley et al. , 1996b . No changes were observed in NH 3 concentration in the hepatic vein, while that in the portal vein increased (P Ͻ 0⋅003) by 191 (C150) and 400 (C400) mol/l during the NH 4 HCO 3 administration. The increases in portal NH 3 concentration were larger than would be expected (i.e. 125 and 290 mol/l for C150 and C400 respectively) on the basis of the portal blood flow, basal portal NH 3 concentration and the infusion rates of NH 4 HCO 3 . The arterial concentrations of urea increased by 1⋅63 and 3⋅65 mmol/l after the 4 d infusion of NH 4 HCO 3 at 150 and 400 mol/min (P Ͻ 0⋅05), with parallel responses in the portal and hepatic venous concentrations.
With the exception of leucine, which increased (P Ͻ 0⋅05) from 157 mol/l in C0 to 186 mol/l in C400, no changes were detected in the arterial concentration of amino acids as a result of the infusion of NH 4 HCO 3 (results not shown). Regardless of the treatment, plasma concentrations of several amino acids (e.g. phenylalanine, P Ͻ 0⋅06; leucine, P Ͻ 0⋅01; isoleucine, P Ͻ 0⋅08; results not shown) in the first experimental period were lower than in subsequent periods.
Blood flow, gas exchange and glucose transfers (Table 2)
The blood flows in the portal and hepatic veins were not altered by NH 4 HCO 3 infusion. The small contribution of the hepatic artery to the liver blood flow (6 %) was also unaltered. The liver and the PDV each accounted for 0⋅5 of the O 2 consumption measured across the splanchnic bed (3⋅20 mmol/min) in C0. Based on the traditional estimation of 0⋅66 mol O 2 /mol urea (i.e. 4 ATP/mol urea), urea synthesis would account for 0⋅15 of liver energy expenditure under basal dietary conditions. The O 2 consumption by both tissues showed an upward trend during the infusion of 400 mol NH 4 HCO 3 /min, but only 0⋅54 of the observed increase in liver O 2 consumption could be theoretically accounted for by the additional urea synthesised. Basal glucose uptake by the PDV was, at 32 mol/min, 0⋅10 of that released by the liver, with neither altered by the administration of NH 4 HCO 3 .
Ammonia and urea transfers (Table 2)
Dietary N intake was 16⋅4 g/d −1
, equivalent to 815 mol N/min under continuous feeding conditions. Although urea transfer to the gastrointestinal tract (GIT) remained constant at 0⋅45-0⋅47 of liver production across all three treatments, the absolute transfer increased with both levels of NH 4 HCO 3 infusion (P Ͻ 0⋅02). This endogenous urea-N recycling to the GIT was equivalent to 0⋅40-0⋅75 of ingested N.
Basal NH 3 appearance in the portal vein (y, mol/min; i.e. net NH 3 appearance corrected for the infusion rate of NH 4 HCO 3 ) amounted to 0⋅42 of dietary N intake in C0, increased by 95 and 164 mol/min in C150 and C400 respectively (P Ͻ 0⋅02), and showed a linear correlation with urea-N transfer to the GIT (x, mol/min; y = 188⋅5 (SE 43⋅12) + 0⋅53 (SE 0⋅091) x; P Ͻ 0⋅001; RMS 1324⋅8; R 2 0⋅83).
Liver extraction of NH 3 was augmented (P Ͻ 0⋅001) in response to the NH 3 load and was 1⋅02-1⋅14 higher than NH 3 appearance across the PDV, indicating that the liver also removed NH 3 released from non-splanchnic tissues. Urea-N production by the liver was 1⋅81 times the basal NH 3 uptake for treatment C0 and rose significantly by 202 and 646 mol/min following the infusion of 150 and 400 mol NH 4 HCO 3 /min. Similar trends were observed for urea ILR (y, mol/min), which showed good concordance with hepatic urea production (x, mol/min; y = 321⋅4 (SE 160⋅38) + 0⋅734 (SE 0⋅155) x ; P = 0⋅002; P b 1 = 0⋅13; RMS 18137⋅77; R 2 0⋅76). A strong linear relationship was observed between urea-N release (y, mol/min) and NH 3 extraction (x, mol/min) across the liver, with the slope of the regression equation not different from unity, regardless of whether estimations were based on GC-mass spectrometry analysis (y = 241⋅3 (SE 100⋅05) + 1⋅16 (SE 0⋅144) x; P Ͻ 0⋅001; P b 1 = 0⋅31; RMS 10626⋅8; R 2 0⋅89; Fig. 1 
) or [
14 C]urea IRL (y = 409⋅5 (SE 84⋅60) + 0⋅97 (SE 0⋅123) x; P Ͻ 0⋅001; P b 1 = 0⋅84; RMS 7597⋅6; R 2 0⋅89).
Amino acid transfers (Table 3)
For all treatments there was net absorption of amino acids across the PDV and net removal by the liver, with the exception of glutamate, citrulline and ornithine, which exhibited net release by the liver (results not shown). Initial calculations also showed a net hepatic release of valine;
later studies revealed that a non-identified peak co-chromatographed with valine and interfered with the determination of plasma valine concentrations. Valine data were, therefore, not included in the estimation of net PDV, hepatic and total splanchnic transfers of total, essential and branchedchain amino acids. Under basal dietary conditions, net amino acid-N absorption by the GIT (316 mol/min) accounted for 0⋅38 of the dietary N intake (or 0⋅28 of dietary N plus urea-N inputs to the GIT). The movement of amino acids across the PDV remained unaltered by the infusion of either level of NH 4 HCO 3 (P Ͼ 0⋅05), although portal appearances of arginine (P Ͻ 0⋅03) and non-essential amino acids (P Ͻ 0⋅04) increased while those of total amino acid-N (see Table 2 ), threonine, asparagine, glutamate, glutamine and glycine also tended to be greater (P Ͻ 0⋅1; results not shown) at the highest level of infusion. Net absorption of amino acid-N and urea-N removal by the GIT were highly correlated (R 2 0⋅84; Fig. 2 ). Hepatic extraction of total, essential, non-essential, branched-chain, glucogenic or individual amino acids was unaltered by the treatments. Hepatic extraction of total amino acid-N accounted, on average, for 0⋅82 of the amino acid-N appearance across the PDV. The hepatic fractional removal (hepatic removal : PDV appearance) varied markedly among individual amino acids, however, being close to, or higher than, unity for tyrosine, phenylalanine, histidine, threonine and the glucogenic serine, alanine, glycine and glutamine (the latter removed at a rate seven times higher than the PDV appearance), intermediate (0⋅5-0⋅7) for methionine and lysine and lowest (Ͻ 0⋅2) for leucine and isoleucine (results not shown).
Liver nitrogen balance
The net balance of N across the liver (estimated as: NH 3 removal + free amino acid-N removal − urea-N release) was not affected by the NH 4 HCO 3 infusion and averaged −21 (SEM 21⋅8) mol/min. 
Discussion
The present study was designed to address the question of whether increasing the portal supply of NH 3 to the liver could alter the availability of energy and amino acids to non-splanchnic tissues, thus compromising protein and energy deposition in growing male lambs. Data from previous studies in vivo and in vitro indicated that both phenomena might indeed arise under conditions of high input of NH 3 to the liver, but the information available was controversial on both a qualitative and a quantitative basis because NH 3 was not the only variable modified by the treatments (Orzechowski et al. 1988; Reynolds et al. 1991; Lobley et al. 1995; Luo et al. 1995) . In most cases either nutrient supply or acid-base status had also been altered and, thus, the interpretation of the results was confounded. In order to minimize these problems an experimental design was adopted in which only one variable, the NH 3 supply to the liver, was modified by direct infusion of two levels of NH 4 HCO 3 into the mesenteric vein.
Liver oxygen consumption and gluconeogenesis
There is little disagreement, at present, that stimulation of ureagenesis increases liver O 2 consumption (e.g. Reynolds et al. 1991) ; the resultant elevated energy expenditure will reduce whole-body energy deposition. Yet doubts still exist about the actual magnitude of this effect. The measured increase in liver O 2 consumption during the administration of NH 4 + into the mesenteric vein has usually ranged from 1⋅5 to 5⋅5 mol O 2 per additional mol of urea synthesized (i.e. 2-8-fold greater than theoretical estimates based on 4 ATP or 0⋅66 mol O 2 per mol urea synthesized; Milano, 1994; Lobley et al. 1995 Lobley et al. , 1996b . With the exception of determinations carried out in fasted sheep infused with NH 4 HCO 3 (Milano, 1994) , the differences with pre-infusion levels never achieved statistical significance. 
TA, total amino acids (Asp, Asn, Glu, Gln, Ser, Gly, Ala, Tyr, Arg, Thr, Met, Ile, Leu, Phe, Lys, His, Cit, Orn); EA, essential amino acids (Thr, Met, Ile, Leu, Phe, Lys, His); BA, branched chain amino acids (Leu, Ile); NA, non-essential amino acids (Asp, Asn, Glu, Gln, Ser, Gly, Ala, Tyr, Arg); GA, glucogenic amino acids (Ser, Gln, Gly, Ala). * For details of procedures, see pp. 308-309. † Positive and negative values indicate net production and net extraction of the metabolite by the relevant organ respectively. ‡ The data were analysed by ANOVA, with 2 d.f. for the error term; t (0⋅05, 2) = 4⋅30. This experiment is, unfortunately, no exception in that the largest average increase in liver O 2 consumption (393 mol/ min or 1⋅2 mol O 2 per additional mol urea synthesized, for C400) was 1⋅85 times higher than the expected theoretical maximum but the variance was, again, large (SED 174 mol O 2 /min, P = 0⋅13). If energy expenditure elicited by NH 3 -stimulated ureagenesis exceeds theoretical values then other reactions (e.g. transport of substrates across subcellular membranes, intrahepatic cycling of glutamine) must be also enhanced. Lately, however, it has been pointed out that if the traditional P : O of 3 : 1 were replaced by other less efficient ratios (e.g. 2 : 1 or even 1⋅5 : 1; see Lobley, 1994) , then much of the discrepancy between theoretical considerations and empirical evidence would disappear.
Studies in isolated sheep hepatocytes have revealed that gluconeogenesis from propionate could be depressed by 20-40 % at NH 4 Cl concentrations of 500-660 mol/l (Weekes et al. 1978; Luo et al. 1995) . When this was tested in vivo, however, the results were contradictory. Liver glucose output was either depressed by 48 % (Orzechowski et al. 1988) or unaltered (Barej et al. 1987 ) during short-term infusions (120 min) of NH 4 Cl into the mesenteric vein of sheep at rates sufficient to achieve portal concentrations of 800-850 mol/l and exceed the capacity of the liver for NH 3 removal (1⋅5 mol/min per g wet tissue). In the present experiment, hepatic glucose production remained unaffected after a 4 d administration of NH 4 HCO 3 and at similar portal NH 3 flows and concentrations (i.e. 740 mol/l in C400) to the previous studies. This suggests that the high portal NH 3 load that may occur in ruminants, e.g. those given rations with a high non-protein-N content or fresh forage rich in rapidly degradable protein, does not impair liver glucose supply for extra-hepatic tissue metabolism.
Ammonia, urea and amino acid transfers
Experimental evidence obtained from studies of splanchnic transfer of N-compounds over the last decade (see reviews of Reynolds, 1992; Parker et al. 1995; Lescoat et al. 1996) , indicated that, on an incremental basis, removal of NH 3 by the liver is associated with a larger than equimolar release of urea-N; the slope of the regression of urea-N release v. NH 3 uptake across studies ranged between 1⋅6 and 1⋅9. Free amino acids were the only N-compounds available to the liver in sufficient amounts to provide the additional N. This led to the hypothesis that amino acid availability for hepatic synthesis of export proteins, or for non-splanchnic tissue utilization, would be progressively reduced as the rate of NH 3 removal by the liver increased (Reynolds, 1992; Parker et al. 1995) .
The hypothesis gained further support from long-term studies in sheep. When the basal rate of hepatic NH 3 removal was increased by continuous administration of NH 4 Cl into the mesenteric vein for 5 d, not only was the additional urea-N released from the liver 2-fold greater than the additional NH 3 removed but whole-body leucine oxidation increased significantly by 18 % (Lobley et al. 1995) . Slight decreases in plasma pH (0⋅08 units) and plasma HCO 3 − concentration (5 mmol/l) were also reported during the NH 4 Cl infusions. Studies in human subjects (Reaich et al. 1992 ) and rodents (May et al. 1992) have demonstrated that acidosis elicited by the administration of NH 4 Cl can stimulate protein breakdown and amino acid oxidation, leaving a surplus of amino acid-N available for urea synthesis. Thus, it was unclear whether the higher leucine oxidation and the additional N appearing in urea observed by Lobley et al. (1995) were consequences of the higher NH 3 removal or of the concomitant mild acidosis. In a subsequent study, in which acidosis was avoided by a continuous 4 d infusion of NH 4 HCO 3 into the mesenteric vein, the incremental values for urea-N release : NH 3 removal across the liver of growing lambs were 1⋅12 and 1⋅17 after hepatic NH 3 uptake was increased by 208 or 325 mol/min respectively (Lobley et al. 1996b) . The nutritional conditions involved were, however, substantially different, with a higher feed intake (2⋅0 v. 1⋅2 times energy maintenance) compared with the initial experiment of Lobley et al. (1995) . This increased markedly the amino acid-N absorbed by the animals (1155 v. 372 mol/min) and reduced the ratio NH 3 : amino acid-N appearing in the portal vein from 1⋅3-1⋅9 to 0⋅5-0⋅8, lower than expected for diets with high non-protein-N content (1⋅1-1⋅5; Maltby et al. 1991) . In addition, it is well established that the activity of urea cycle enzymes is enhanced in response to high-protein diets, primarily as a consequence of changes in enzyme mass (Morris, 1992) . There was concern, therefore, that these changes may have altered the hepatic capacity to handle excess NH 3 , as shown in the perfused rat liver, where the ability to form urea from 600 M-NH 4 Cl increased with the amount of casein in the diet (Saheki, 1972) .
Thus, the present experiment was designed to meet two fundamental criteria. First, the acid-base status of the animals remained unchanged during the administration of NH 4 + and, in this respect, the choice of the bicarbonate salt seemed appropriate because it had been used without obvious alteration of the acid-base status in two experiments at a rate similar to that of C150 (Milano, 1994; Lobley et al. 1996b) . At higher doses, however, NaHCO 3 had been shown to cause acute metabolic alkalosis in rats (Boon et al. 1994) and dogs (Rodriguez et al. 1989) . This raised concerns about the possible long-term increase in plasma HCO 3 − concentration with the highest level of NH 4 HCO 3 infusion (C400). Nevertheless, the acid-base status of the sheep remained within the normal range throughout the experiment. Second, amino acid-N appearance across the PDV had to match that reported by Lobley et al. (1995) (i.e. 406 v. 372 mol/min) but at comparatively higher rates of hepatic NH 3 removal (900 v. 600 mol NH 3 /min). It was, therefore, critical that the additional source of N would not alter the net amino acid supply to the lambs. It was expected that some of the urea synthesized by the liver, as a result of the infusion of NH 4 HCO 3 , would be transferred to the GIT. This could increase net microbial protein yield if the basal (C0) rumen degradable N supply was below that required to sustain optimum microbial protein yield in vivo (29-32 g N/ kg organic matter truly digested in the rumen; Agricultural and Food Research Council, 1993) . Any additional amino acid absorption could result in increased urea synthesis and tend to lower the apparent efficiency of conversion of NH 3 to urea. The marked trend towards higher values of PDV amino acid-N absorption in C400 and the linear correlation between amino acid-N and urea-N transfers across the PDV suggest that the assumption of unchanged amino acid supply did not hold for the highest level of infusion.
Nevertheless, the slope of the regression of hepatic urea-N release (1⋅16; SE 0⋅14) or [ 14 C]urea-N IRL (0⋅97; SE 0⋅12) on hepatic NH 3 removal, together with the steady hepatic amino acid extraction observed under these experimental conditions support earlier observations in vivo in steers (Maltby et al. 1991) and sheep (Lobley et al. 1996b) (Luo et al. 1995; Brosnan et al. 1996) , have provided evidence that NH 3 -N can enter the ornithine cycle by two separate routes: synthesis of carbamoyl phosphate, through a reaction catalysed by carbamoyl phosphate synthase I, and reductive amination of 2-oxoglutarate followed by transamination to aspartate, a pathway controlled by glutamate dehydrogenase (GDH) and aspartate aminotransferase. If the additional NH 3 supply to the liver in the current experiment was converted to urea-N without extra amino acid-N inputs to the ornithine cycle, then the GDH-aspartate aminotransferase pathway must have had the capacity to utilize half the extra NH 3 removed. For C400, for example, this required an additional flux of 281 mol N/min to glutamate and aspartate synthesis, which represents an 8-fold increase in the net flux through GDH (calculated as: liver NH 3 removal − (0⋅5 × urea-N release)), from an estimated basal rate (C0) of 36 mol N/min. The capacity of liver GDH to utilize excess NH 3 to synthesize glutamate is, therefore, central to the question of detoxifying NH 3 with or without alteration in the partition of amino acid-N flow towards ureagenesis.
The current study indicates that the capacity of GDH to meet such demands is either inherent or can be adapted when portal NH 3 input to the liver is augmented and sustained for 4 d at nearly 3-fold that in basal conditions. Distinction between these mechanisms seems of less practical significance for long-term than for short-term (i.e. 2-3 h) increases in NH 3 supply to the liver. The former (i.e. intrinsically high liver GDH activity) would be of importance to allow removal of acute excesses of NH 3 without penalizing amino acid availability to the animal.
Confirmation of equal partition of the additional NH 3 inputs to the liver between the GDH-aspartate aminotransferase and carbamoyl phosphate synthase I pathways requires further experimentation, however. First, it is not certain that the conclusions of the current, and previous, experiments in growing lambs and steers can be extrapolated to other diets (e.g. fresh grass or legumes), feeding routines (e.g. discontinuous feeding) and physiological conditions (e.g. pregnancy, lactation) where different balances of hormones and nutrients (e.g. propionate) may occur. Second, the deviation from unity of the slope of the regression of urea-N release v. NH 3 removal across the liver (i.e. 0⋅16) might still represent a minor, but not negligible, stimulation of amino acid-N utilization for ureagenesis. With a 300 mol/ min increase in hepatic NH 3 extraction, for example, the deviation of the ratio from unity observed in the current study would amount to 0⋅96 g N/d. Moreover, enhancement of amino acid oxidation during sustained increase of NH 3 inputs to the liver could be entirely unrelated to limitations in N flux through GDH, because amino acids could also be used as energy substrates to meet the increased demands of hepatic ureagenesis. In C400, for example, with an increase in liver O 2 consumption of 393 mol/min, an extra 84 mol amino acid-N per min might have been oxidized to provide the necessary energy to sustain ureagenesis (i.e. 176 J/min, based on 448 kJ/mol O 2 and 24 MJ/kg protein or 2⋅1 kJ/mol protein N). The numerical agreement between this value and the additional amino acid-N flow to urea in C400 as measured by GC-mass spectrometry (83 mol/min, estimated from additional urea-N release − additional NH 3 removed across the liver) is remarkable, but probably coincidental. 
